Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Akela Pharma has received a development contract from Pear Tree Pharmaceuticals, at its PharmaForm subsidiary located in Austin, Texas, for the development of two different drug products for treatment of atrophic vaginitis.
Subscribe to our email newsletter
PharmaForm will develop the drug products to deliver Pear Tree’s confidential drug substances to the vaginal cavity.
Stephen Rocamboli, president of Pear Tree Pharmaceuticals, said: “We are pleased to be working with PharmaForm on these important products. We believe PharmaForm’s recognized expertise in drug product development and delivery to the vaginal cavity will help us accelerate our program strategies.”